ArriVent BioPharma Reports Second Quarter 2026 Financial Results
Go back to ArriVent BioPharma Reports Second Quarter 2026 Financial Results| (NASDAQ: AVBP) | Delayed: 15.67 -0.42 (2.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.09 | 52 Week High | $ | |||
| Open | $16.06 | 52 Week Low | $ | |||
| Day High | $16.15 | P/E | N/A | |||
| Day Low | $15.26 | EPS | $ | |||
| Volume | 851,121 | |||||



